Phase 4 Endometriosis Trial, Recruiting (NCT05837624)

Phase 4 Endometriosis Trial, Recruiting NCT05837624 Sponsor: Andrew Zakhari Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT05837624 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have at least one ovarian cyst caused by endometriosis that is at least 3 cm in size
You are looking for a hormonal treatment for your endometriosis-related ovarian cyst(s)

Who may not be able to join:

You have an allergy or a medical reason why you cannot take the medication being studied
You are not able to give your informed consent to take part in the trial
You have used certain hormonal medications in the last 3 months, including estrogen, progestogen, androgens, GnRH-related medications, or cabergoline — note that hormones used specifically for fertility treatments (to stimulate your ovaries) do not count toward this (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Andrew Zakhari, M.D., McGill University Health Centre/Research Institute of the McGill University Health Centre

Phone: 5142288889

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05837624

Sponsor: Andrew Zakhari

Phase: Phase 4

Status: Recruiting

Condition: Endometriosis

Trial contact: 5142288889

More information: https://clinicaltrials.gov/study/NCT05837624

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have at least one ovarian cyst caused by endometriosis that is at least 3 cm in size
You are looking for a hormonal treatment for your endometriosis-related ovarian cyst(s)

Who may not be able to join:

You have an allergy or a medical reason why you cannot take the medication being studied
You are not able to give your informed consent to take part in the trial
You have used certain hormonal medications in the last 3 months, including estrogen, progestogen, androgens, GnRH-related medications, or cabergoline — note that hormones used specifically for fertility treatments (to stimulate your ovaries) do not count toward this (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Andrew Zakhari

Registry

ClinicalTrials.gov

Start date

3 December 2024

Est. completion

1 November 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in ovarian endometrioma volume at 6-months (from baseline)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov